1.Efficacy of ciprofloxacin and dexamethasone in experimental pseudomonas endophthalmitis.
In Taek KIM ; Kee Ha CHUNG ; Bon Sin KOO
Korean Journal of Ophthalmology 1996;10(1):8-17
To determine injection time and effective dose of ciprofloxacin in endophthalmitis and to evaluate the effectiveness of dexamethasone. In rabbits, Pseudomonas aeruginosa (2 x 10(4) CFU/0.1 ml) was inoculated intravitreally. At 6, 12, 18, 24 hours postinoculation, single intravitreal doses of ciprofloxacin (300 microgram/0.15 ml or 100 microgram/0.05 ml) alone or with dexamethasone (400 microgram) were given. Electrophysiological and histologic measures were utilized to rate drug effectiveness. 300 micrograms ciprofloxacin was effective in killing P. aeruginosa at 6 and 12 hours postinoculation, but one hundred ug ciprofloxacin was not effective. 300 ug ciprofloxacin had no significant effect in killing P. alphaeruginosa at 18 hrs and 24 hrs postinoculation. Eyes treated with dexamethasone (400 microgram) and ciprofloxacin (300 microgram) at 6 hours postinoculation did not differ from eyes treated with ciprofloxacin alone. Cultures from eyes treated with dexamethasone and ciprofloxacin at 12 hours postinoculation were positive. Cultures from eyes treated with ciprofloxacin alone were negative. The failure of treatment at 18 hrs and 24 hrs postinoculation may be due to either an increased rate of clearance of drugs from the eyes or a reduced bactericidal effect of ciprofloxacin which could be altered by acidic pH, degree of hypoxia or bacterial counts. Dexamethasone had no beneficial effect in the treatment of P. aeruginosa endophthalmitis in the early phase.
Animals
;
Anti-Infective Agents/*administration & dosage
;
Anti-Inflammatory Agents/*administration & dosage
;
Ciprofloxacin/*administration & dosage
;
Dexamethasone/*administration & dosage
;
Disease Models, Animal
;
Dose-Response Relationship, Drug
;
Drug Therapy, Combination
;
Electroretinography
;
Endophthalmitis/*drug therapy/microbiology/pathology
;
Eye Infections, Bacterial/*drug therapy/microbiology/pathology
;
Pseudomonas Infections/*drug therapy/microbiology/pathology
;
Pseudomonas aeruginosa/drug effects/isolation & purification
;
Rabbits
;
Time Factors
;
Vitreous Body/microbiology
2.A Case of Stenotrophomonas maltophilia Keratitis Effectively Treated with Moxifloxacin.
Sung Whan SON ; Hyung Jin KIM ; Jeong Won SEO
Korean Journal of Ophthalmology 2011;25(5):349-351
A 70-year-old man with a long history of diabetes mellitus presented to our hospital (Department of Ophthalmology, Sahm Yook Medical Center, Seoul, Korea) complaining of severe ocular pain and visual disturbance in his left eye that had started three days prior to admission. A round 3.7 x 5.0 mm dense central stromal infiltrate with an overlying epithelial defect was noted on slit-lamp examination. Following corneal scrapings and culture, topical 0.5% moxifloxacin and 0.5% tobramycin were administered hourly. A few days later, Stenotrophomonas maltophilia was isolated in a bacterial culture from a corneal specimen. According to the results of susceptibility tests, topical 0.5% moxifloxacin was given every hour and 0.5% tobramycin was stopped. The patient's clinical features improved steadily with treatment. The corneal epithelium healed rapidly, and the infiltrate resolved within four weeks of the initiation of treatment. The patient's best corrected visual acuity improved from hand motion to 20 / 25.
Aged
;
Anti-Infective Agents/administration & dosage
;
Aza Compounds/*administration & dosage
;
Cornea/*microbiology/pathology
;
Diagnosis, Differential
;
Eye Infections, Bacterial/diagnosis/*drug therapy/microbiology
;
Follow-Up Studies
;
Gram-Negative Bacterial Infections/diagnosis/*drug therapy/microbiology
;
Humans
;
Keratitis/diagnosis/*drug therapy/microbiology
;
Male
;
Ophthalmic Solutions
;
Quinolines/*administration & dosage
;
Stenotrophomonas maltophilia/*isolation & purification
;
Visual Acuity
3.A Case of Stenotrophomonas maltophilia Keratitis Effectively Treated with Moxifloxacin.
Sung Whan SON ; Hyung Jin KIM ; Jeong Won SEO
Korean Journal of Ophthalmology 2011;25(5):349-351
A 70-year-old man with a long history of diabetes mellitus presented to our hospital (Department of Ophthalmology, Sahm Yook Medical Center, Seoul, Korea) complaining of severe ocular pain and visual disturbance in his left eye that had started three days prior to admission. A round 3.7 x 5.0 mm dense central stromal infiltrate with an overlying epithelial defect was noted on slit-lamp examination. Following corneal scrapings and culture, topical 0.5% moxifloxacin and 0.5% tobramycin were administered hourly. A few days later, Stenotrophomonas maltophilia was isolated in a bacterial culture from a corneal specimen. According to the results of susceptibility tests, topical 0.5% moxifloxacin was given every hour and 0.5% tobramycin was stopped. The patient's clinical features improved steadily with treatment. The corneal epithelium healed rapidly, and the infiltrate resolved within four weeks of the initiation of treatment. The patient's best corrected visual acuity improved from hand motion to 20 / 25.
Aged
;
Anti-Infective Agents/administration & dosage
;
Aza Compounds/*administration & dosage
;
Cornea/*microbiology/pathology
;
Diagnosis, Differential
;
Eye Infections, Bacterial/diagnosis/*drug therapy/microbiology
;
Follow-Up Studies
;
Gram-Negative Bacterial Infections/diagnosis/*drug therapy/microbiology
;
Humans
;
Keratitis/diagnosis/*drug therapy/microbiology
;
Male
;
Ophthalmic Solutions
;
Quinolines/*administration & dosage
;
Stenotrophomonas maltophilia/*isolation & purification
;
Visual Acuity
4.Pediatric Infectious Endophthalmitis: A 271-case Retrospective Study at a Single Center in China.
Meng ZHANG ; Ge-Zhi XU ; Rui JIANG ; Ying-Qin NI ; Ke-Yan WANG ; Rui-Ping GU ; Xin-Yi DING
Chinese Medical Journal 2016;129(24):2936-2943
BACKGROUNDPediatric infectious endophthalmitis is a serious sight-threatening disease for children. The purpose of this study was to investigate the etiology, microbiological spectrum, and visual outcomes of infectious endophthalmitis in children at a single institution in China.
METHODSIt is a retrospective study of the medical records of all patients under 14 years of age with histories of infectious endophthalmitis, treated at a single institution from January 1, 2009 to January 1, 2015. The clinical characteristics, etiology, microbiological spectrum, and management, as well as the visual outcomes, were analyzed. The Kappa test and Chi-square test were used in the statistical evaluation.
RESULTSA total of 271 children were identified, with a mean age of 5.61 ± 2.93 years (range 5 months to 14 years). Ocular trauma (94.8%) and previous ocular surgery (3.0%) were the most common etiologies. Overall, 147 (54.2%) cases had positive cultures, and 176 organisms were isolated from these patients. A single species was isolated in 120 (81.6%) cases, with multiple organisms in 27 (18.4%) cases, and the most commonly identified organisms were coagulase-negative Staphylococcus and Streptococcus species, comprising 29.5% and 26.8% of the isolates, respectively. Moreover, of 176 isolates, 142 (80.8%) were Gram-positive organisms, 23 (13.0%) were Gram-negative organisms, and 11 (6.2%) were fungi. The final visual outcomes were 20/200 or better in 66 (24.4%) eyes, counting fingers to 20/200 in 34 (12.5%), hand motions in 30 (11.1%), light perception in 33 (12.2%), no light perception in 32 (11.8%), and 9 (3.3%) eyes were enucleated or eviscerated. The visual outcomes were not available in 67 (24.7%) patients.
CONCLUSIONSPenetrating ocular trauma is the most frequent cause of pediatric endophthalmitis in China. Streptococcus and Staphylococcus species are the most commonly identified organisms in exogenous pediatric endophthalmitis whereas Fusarium species are commonly seen in endogenous endophthalmitis. In this research, in spite of aggressive management with antibiotics and vitrectomy, the visual prognosis was found to be generally poor.
Adolescent ; Anti-Bacterial Agents ; therapeutic use ; Child ; Child, Preschool ; China ; Endophthalmitis ; drug therapy ; microbiology ; pathology ; Eye Infections, Fungal ; drug therapy ; microbiology ; pathology ; Eye Injuries, Penetrating ; microbiology ; Female ; Fusarium ; pathogenicity ; Humans ; Infant ; Male ; Retina ; microbiology ; Retrospective Studies ; Staphylococcus ; pathogenicity ; Streptococcus ; pathogenicity ; Vitrectomy
5.Endogenous Aeromonas Hydrophila Endophthalmitis in an Immunocompromised Patient.
Hee Jin SOHN ; Dong Heun NAM ; Yeon Suk KIM ; Hae Jung PAIK
Korean Journal of Ophthalmology 2007;21(1):45-47
PURPOSE: To report a case of endogenous endophthalmitis due to Aeromonas hydrophila in a patient with distal common bile duct carcinoma and biliary sepsis. METHODS: A 72-year-old woman with distal common bile duct carcinoma, obstructive jaundice, diabetes mellitus, and hypertension had a 1-day history of blurred vision, redness, and eye discharges in the right eye. An ophthalmic examination showed no light perception vision, increased intraocular pressure, severe corneal edema, severe anterior chamber reaction, exudative membranes on the anterior lens surface, and severe vitreal reaction. There was no ocular history of trauma, infection, or surgery in either eye. RESULTS: Under the impression of endogenous bacterial endophthalmitis, immediate intraocular cultures and intravitreal antibiotic injections were performed, but the anterior chamber reaction, and the ultrasonogram findings were deteriorated. Evisceration was undertakened because of extrusion of the intraocular contents, and Aeromonas hydrophila was isolated by intraocular culture. CONCLUSIONS: Endogenous endophthalmitis due to Aeromonas hydrophila is rare, but has a rapid clinical course and a poor prognosis, despite of prompt diagnosis and management.
Vitreous Body
;
Ultrasonography
;
Treatment Failure
;
Tomography, X-Ray Computed
;
Injections
;
*Immunocompromised Host
;
Humans
;
*Gram-Negative Bacterial Infections/drug therapy
;
Female
;
Eye Evisceration
;
Endophthalmitis/diagnosis/*microbiology/pathology
;
Anti-Bacterial Agents/administration & dosage/therapeutic use
;
Aged
;
*Aeromonas hydrophila